Group items tagged

Stem Cell Centre is providing best stem cell treatment in india under well trained expertise. Stem Cell Therapy in delhi, India.

Stem cells can be divided into two broad types of cells: embryonic and adult stem cells. Embryonic stem cells are derived from the early embryonic tissue which we do not use for ethical reasons. Stem cells are defined by two properties: First, they can self-regenerate, that is they can divide and give rise to more stem cells of the same kind. Second, they can mature or differentiate into specialised cells that carry out a specific function, such as in the skin, muscle, or blood.

Intelli health plus provide medical clinic specializing in Anti-Aging, Cell Therapy, Cosmetic surgery, lasers, skin care and Regenerative Medicine. Our Integrative approach in Medicine offers individualized treatment programs for patients of all ages and with various disorders.

Intelli health plus provide medical clinic specializing in Anti-Aging, Cell Therapy, Cosmetic surgery, lasers, skin care and Regenerative Medicine. Our Integrative approach in Medicine offers individualized treatment programs for patients of all ages and with various disorders.

stem cell therapy for optic nerve atrophy proved to be the most effective treatment measure for any individual. With stem cell therapy in India, the damaged optic nerve cells get replaced with the newer ones created from the stem cells collected from the bone marrow. Thus, the patient gets the best treatment.

Stem cell therapy in India is considered to be one of the safest options to protect an individual from life taking disease.

The best stem cell therapy center in India, which has been a game changer in the treatment of patients with neurodegerative and neurodevelopmental disorders.

PRP means platelet-rich plasma. Patients' blood is taken and put in a centrifuge machine to get platelet concentrate.The platelets are injected into the scalp. There are various growth factors in platelet which work on stem cells of hair follicles and activate those stem cells. PRP therapy is very effective when the concentration of platelets are three to five times than normal concentration in blood. PRP effectively controls hair loss and makes weak hair stronger. At rejuvenate hair transplant center the results of PRP is very effective.

Mr.Fida Mohammad, 63 years from Peshawar Pakistan was a healthy and active gentleman till about 5 years ago when he started feeling some weakness in the thumb on the left leg. Slowly, he started getting incidences of foot drops, and within one year of starting of symptoms, he was unable to walk and was confined to a wheelchair. He also lost the power in the upper limbs shortly afterwords. He got in touch with the best neurological centers in Pakistan and was diagnosed with Motor Neuron Disease (MND). The disease continues to progress and slowly his power to speak and usage of all 4 limbs got affected. That is when the family started researching on the internet for alternative treatments. They studied stem cells on the internet and their local doctors advised them to go for the treatment which promised to stabilize the disease and stop its progression. They got in touch with Advancells, Delhi, India, and sent over their medical reports to be analyzed. Experts at Advancells counseled the family by explaining the treatment procedure, risks, and success rates and advised them to go for stem cell therapy.

A novel stem cell therapy given shortly after a kidney transplant allows some patients to cast away the medicines meant to keep their body from attacking the new organ, according to a small new study from the Stanford University School of Medicine.

Integrative Cancer Science and Therapeutics welcomes submission of papers both at the molecular, subcellular, cellular, organ, and organism level, and of clinical proof-of-concept and translational studies. Topics of interest include, but are not limited to: novel basic cancer research discoveries, cell and tumor biology, animal models, metastasis, cancer antigens and the immune response to them, cellular signalling and molecular biology, epidemiology, genetic and molecular profiling of cancer and molecular targets, cancer stem cells, cancer-associated pathways (including cell-cycle regulation; cell death; chromatin regulation; DNA damage and repair; gene and RNA regulation; genomics; oncogenes and tumor suppressors; and signal transduction), molecular virology and vaccine- and antibody-based cancer therapies, and other cancer-related research.

Aplastic Anemia is a rare but serious disease of the blood cells. It is diagnosed by the inability of the bone marrow to synthesize RBCs, WBCs and platelets. The spongy bone marrow contains stem cells that are actively involved in Hematopoiesis.

The peak in the number of deaths that stem from heart diseases, is on an increasing scale, every single year. According to research, blood pressure, obesity, inactivity, and high cholesterol levels are contributors to cardiovascular diseases. A sedentary… Read More »

British pharmacy chain Superdrug has announced plans to cease the sale of disposable vapes in all its UK and Ireland stores, citing the environmental impact caused by its disposal and popularity among young people. The pharmacy retailer will discontinue selling brands like Vuse GO and Flavaah Bars, with plans to completely clear out existing stock by the end of the year, the company said in statement. Superdrug, which previously sold 1,300 single-use vapes weekly, expects a potential impact on revenue stemming from this decision. The company has not yet started selling vapes online. "This decision was made to safeguard the environment," the company said on Sept.22, highlighting the risk of fires due to improper disposal of vapes, as many of them contain lithium batteries.

The world has never been in a better position to end the Covid-19 pandemic, the head of the World Health Organization said on September 14, his most optimistic outlook yet on the years-long health crisis which has killed over six million people. "We are not there yet. But the end is in sight," WHO Director-General Tedros Adhanom Ghebreyesus told reporters at a virtual press conference. That was the most upbeat assessment from the UN agency since it declared an international emergency in January 2020 and started describing Covid-19 as a pandemic three months later. The virus, which emerged in China in late 2019, has killed nearly 6.5 million people and infected 606 million, roiling global economies and overwhelming healthcare systems. The rollout of vaccines and therapies have helped to stem deaths and hospitalisations, and the Omicron variant which emerged late last year causes less severe disease. Deaths from Covid-19 last week were the lowest since March 2020, the U.N. agency reported.

Over the last few years, we've seen the aftermath of Covid-19, with the demand for consumer health products being unprecedented and unpredictable, placing pressure on supply chains and labour market. In turn, the industry has experienced acute shortages across the healthcare sector, placing huge pressure on pharmacists, doctors, nurses, and other healthcare professionals. Europe has an estimated shortage of around 50,000 public-sector doctors[1], which is set to increase in the coming years. While this shortage stems from several complex problems, there is a hidden force that could play a key part in helping to alleviate this burden. That force is the potential of self-care. Encouragingly, last month the UK government recognised the unique role that self-care can play through the introduction of its Delivery plan for recovering access to primary care. Through this, it has pledged to empower patients to manage their own health through several commitments, including improving accessibility to online tools and reclassifying medicines to make formerly prescribed options available over the counter.

The new deal struck by the NHS will enable provision of a life-saving treatment for babies and young children who suffer with a rare and fatal genetic disease, metachromatic leukodystrophy (MLD). The revolutionary gene therapy treatment, known by its brand name Libmeldy, is used to treat MLD, which causes severe damage to the child's nervous system and organs, leading to a life expectancy of just five to eight years. Having a reported list price of more than £2.8 million, it is the most expensive drug in the world, but can now be offered to young patients on the NHS in England after the health service negotiated a significant confidential discount. the drug works by removing the patient's stem cells and replacing the faulty gene that causes MLD before then re-injecting the treated cells into the patient. The most common form of MLD usually develops in babies younger than 30 months and can cause loss of sight, speech and hearing, as well as difficulty moving, brain impairment, seizures, and eventually death.

The Pharmacist's Defence Association (PDA) has raised concerns over the adoption of Digital Clinical Excellence (DiCE) guidelines for online prescribing of GLP-1 receptor agonists for weight management in adults. This follows a clash with expert recommendations commissioned by the General Pharmaceutical Council (GPhC) as the PDA "believes the final guidance conflicts with the expert opinion underpins the GPhC's prosecution strategy towards pharmacist prescribers under investigation." In a recent statement, the PDA highlighted the discrepancy between DiCE's guidance and the expert report employed by the GPhC to prosecute pharmacist prescribers using a questionnaire-based consultation model. This conflict has prompted the PDA to withhold its endorsement of the DiCE guidance as it differs from an expert report commissioned by the GPhC. The PDA's reservations stem from the inherent risks associated with questionnaire-based prescribing.

A report released by Community Pharmacy England (CPE) has warned that pharmacies across England are grappling with daily medicine supply challenges, posing significant risks to patients' health. The Pharmacy Pressures Survey 2024: Medicines Supply Report, which is based on the views of the owners of over 6,100 pharmacy premises in England and 2,000 pharmacy team members, has exposed some alarming trends concerning medicine supply problems in the country. Almost all pharmacy team members surveyed (97 per cent) reported patients being inconvenienced due to medicine supply issues, and 79 per cent of the participants said that the worsening situation is putting patient health at risk. Nearly all respondents reported patient frustration stemming from medicine supply issues, with 84 per cent of them saying they had experienced aggression from patients. Additionally, 98 per cent indicated an increase in 'owings,' where patients receive only part of their prescription and must return to the pharmacy for the remaining medication(s) at a later time."

London's Great Ormond Street Hospital and Alder Hey Children's Hospital in Liverpool are poised to introduce groundbreaking gender-related services in England, following the closure of the Gender Identity Development Service (Gids) operated by the Tavistock and Portman NHS Foundation Trust. Amid concerns expressed by hospital executives regarding the closure of Gids, with leaked emails revealing apprehensions about appointment cancellations and inadequate communication with the new services, the National Health Services England (NHSE) has confirmed "its commitment to ensuring continuity of care for patients already accessing endocrine care in GIDS." NHSE's decision to transition to regional services stems from a 2022 interim review, led by Dr. Hilary Cass, which highlighted the need for improved support structures for gender-distressed youth. It emphasized a significant increase in referrals to Gids, surpassing 5,000 in 2021/22, compared to less than 250 a decade ago.

The British Medical Association (BMA) on Wednesday announced that 33,869 junior doctors have voted in favour of extending the industrial action and the use of action short of strike (ASOS). With a turnout of 62 per cent, their demand stems from the ongoing campaign for complete pay restoration. The new mandate will last till September 19, starting on 3 April. The BMA junior doctors committee co-chairs, Dr Robert Laurenson and Dr Vivek Trivedi, expressed frustration at the year-long strike action, highlighting the government's avoidance tactics to tackle soaring waiting lists, access to GPs and staff shortages. "The government should see the urgency of the situation. Rather than waste time dragging out talks, they can come forward with a credible offer on pay right now. " "Instead, they could be celebrating a revitalised and reinvigorated junior doctor workforce, one that feels that their value has started to be restored. That would be an achievement worth celebrating for everyone and begin to finally turn the tide on the deteriorating workforce crisis," they said.